LADENBURG THALMANN FINANCIAL SERVICES INC. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 388 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,024,000
-0.1%
17,084
-0.2%
0.01%
-14.3%
Q3 2019$1,025,000
-1.4%
17,112
+6.4%
0.01%
-12.5%
Q2 2019$1,040,000
-19.6%
16,084
+1.0%
0.01%
-20.0%
Q1 2019$1,294,000
+58.0%
15,930
+5.3%
0.01%
+42.9%
Q4 2018$819,000
-10.7%
15,133
-14.8%
0.01%
-12.5%
Q3 2018$917,000
+13.9%
17,762
-2.6%
0.01%0.0%
Q2 2018$805,0000.0%18,2400.0%0.01%0.0%
Q1 2018$805,000
-7.4%
18,240
+5.6%
0.01%0.0%
Q4 2017$869,000
-1.5%
17,267
-0.7%
0.01%
-20.0%
Q3 2017$882,000
-0.6%
17,387
-0.2%
0.01%0.0%
Q2 2017$887,000
+29.7%
17,418
+2.3%
0.01%
+11.1%
Q1 2017$684,000
-11.3%
17,034
+5.6%
0.01%
-18.2%
Q4 2016$771,000
+6.9%
16,127
-18.0%
0.01%0.0%
Q3 2016$721,000
+66.9%
19,674
+6.1%
0.01%
+57.1%
Q2 2016$432,000
-15.0%
18,540
+47.8%
0.01%
-22.2%
Q1 2016$508,000
-21.5%
12,546
+20.0%
0.01%
-25.0%
Q4 2015$647,00010,4550.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders